Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Current Opinion in Nephrology and Hypertension|April 12, 2024
Thiazides for kidney stone recurrence preventionMatteo Bargagli, Sven Trelle, Olivier Bonny, et al.
BMJ Open|June 16, 2025
Indapamide or chlorthalidone to reduce urine supersaturation for secondary prevention of kidney stones: protocol for a randomised, double-blind, cross-over trial (INDAPACHLOR)Martin Scoglio, Matteo Bargagli, Felix Rintelen, et al.
Acta Physiologica (Oxford, England)|May 3, 2024
Effects of thiazides and new findings on kidney stones and dysglycemic side effectsMatteo Bargagli, Manuel A Anderegg, Daniel G Fuster
Nature Medicine|January 3, 2025
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trialManuel A Anderegg, Simeon Schietzel, Matteo Bargagli, et al.
Nature Reviews. Nephrology|August 12, 2025
Kidney stone disease: risk factors, pathophysiology and managementMatteo Bargagli, Martin Scoglio, Sarah A Howles, et al.
Bone|May 6, 2010
Sodium/hydrogen exchanger NHA2 in osteoclasts: subcellular localization and role in vitro and in vivoWilly Hofstetter, Mark Siegrist, Alexandre Simonin, et al.
Urolithiasis|August 10, 2020
Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid contentArman Tsaturyan, Elizaveta Bokova, Piet Bosshard, et al.
Evidence-Based Mental Health|January 12, 2017
Exploratory trials in mental health: anything to learn from other disciplines?Sven Trelle
BMC Health Services Research|August 3, 2002
Accuracy of responses from postal surveys about continuing medical education and information behavior: experiences from a survey among German diabetologistsSven Trelle
BJUI Compass|March 9, 2026
Identifying recurrent stone formers with machine learning: A single-centre observational studyPedro Amado, Daniel G Fuster, Matteo Bargagli, et al.
Pageof 27